| BioPharm provides practical, peer-reviewed information to readers
involved in the development and manufacture of pharmaceutical products
through biotechnology and biopharmaceutical technology. The editorial
focus includes the entire scope of applied technologies in biopharmaceutical
development. Full color, monthly + Buyers Guide.
BioPharm International is the only peer-reviewed publication
serving an audited audience of international science and business leaders
involved in the utilization of biotechnology for the development and manufacture
of therapeutics and diagnostics.
Now in it’s 22nd year, BioPharm International continues to reach
over 90%* of the biotech and pharmaceutical companies with the highest
investment in R&D, giving marketers direct access to the core buying
power of the biotech revolution.
Reach Multiple Subscribers From the Top Biotech Companies**
Top Biotech Companies
# of Subscribers
Amgen Inc
438
Genzyme
160
Biogen Idec
96
Cephalon Inc
56
Gilead Sciences Corp
43
Imclone Systems
40
Elan Corp
34
CSL Ltd
30
Millenium Pharmaceuticals Inc 25
Celgene Corp
25
Genentech Inc
20
Chiron Corp (acquired by Novartis) 19
Seronos SA
10
Actelion Ltd
4
Medimmune Inc
2
Source: **Publisher’s Own Data
*BPA June 2008 Statement
List Rental Services
BioPharm International subscribers are top- and mid-level managers who
perform multiple job functions throughout the biopharmaceutical development
process, including quality control and assurance; research and development;
production and manufacturing; and analytical development. The majority
hold key positions at the world's leading biotech and pharmaceutical companies.
Qualified recipients work in biopharmaceutical or biologics manufacturing
or processing; classical pharmaceutical manufacturing; biodiagnostic manufacturing,
process development, discovery and development, or formulation and delivery;
transgenic therapeutic products; specialty or bulk chemical manufacturing;
architecture, engineering or construction; contract research and analytical
services; biotech and biopharm research; the government; educational or
research institutes; or businesses, investment or legal services.
BioPharm International
Email List
BioPharm
International Mail List |
